Ticker Details
Mineralys Therapeutics, Inc.
IPO Date:	February 10, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.46B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.49 | 2.88%
Avg Daily Range (30 D):	$0.80 | 2.83%
Avg Daily Range (90 D):	$0.80 | 2.84%

Institutional Daily Volume
Avg Daily Volume:	.53M
Avg Daily Volume (30 D):	.98M
Avg Daily Volume (90 D):	1.02M

Trade Size
Avg Trade Size (Sh.):	67
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	62

Institutional Trades
Total Institutional Trades:	965
Avg Institutional Trade:	$2.45M
Avg Institutional Trade (30 D):	$2.45M
Avg Institutional Trade (90 D):	$2.52M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.12M
Avg Closing Trade (30 D):	$3.32M
Avg Closing Trade (90 D):	$4.03M
Avg Closing Volume:	158.45K

News

Nov 7, 2025 @ 11:10 PM Data for Lorundrostat in Chronic Kidney Disease an... Source: Mineralys Therapeutics

Sep 7, 2025 @ 12:23 PM These 2 Healthcare Stocks More Than Doubled Recent... Source: Cory Renauer

Sep 5, 2025 @ 1:00 PM Mineralys Therapeutics Presents Subgroup Analyses ... Source: Mineralys Therapeutics

Sep 3, 2025 @ 1:33 AM Mineralys Therapeutics Announces Pricing of Upsize... Source: Mineralys Therapeutics

May 24, 2025 @ 8:30 AM Mineralys Therapeutics Announces Late-Breaking Pre... Source: Mineralys Therapeutics

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2	$-.47	$-.35
Diluted EPS	$-2	$-.47	$-.35
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-151.78M	$-39.34M	$-32.23M
Operating Income / Loss	$-171.5M	$-45.34M	$-38.28M
Cost of Revenue
Net Cash Flow	$-52.23M	$-60.14M	$-44.68M
PE Ratio